Arrowhead Pharmaceuticals (ARWR) Stock Highlights

18.71 | +0.59%

2024-11-21 02:34:59

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Statistics

Range Today

18.03 18.75

Volume Today 792.1K

Range 1 Year

17.05 39.83

Volume 1 Year 310.09M

Range 3 Year

17.05 74.77

Volume 3 Year 758.95M

Range 10 Year

1.2 93.66

Volume 10 Year 3.22B

Highlights

Market Capitalization 2.72B (mid)

Floating Shares 110.49M

Current Price 18.71

Price To Earnings -4.48

Price To Revenue 139.93

Price To Book 8.23

Earnings Per Share -4.76

Payout Ratio 0%

Performance

Latest +0.59%

1 Month -11.28%

3 Months -19.39%

6 Months -24.5%

1 Year -33.32%

3 Years -74.37%

5 Years -62.58%

10 Years +234.11%

Benchmarks

Market Capitalization

45 / 368

Gross Profits

27 / 278

Total Revenue

48 / 300

Total Rank

174 / 368

Free Cashflow

333 / 352

Performance 5 years

184 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.